Today: 20 May 2026
Browse Category

TSX:5801 27 November 2025 - 25 February 2026

Tokyo stock market today: Nikkei hits new record as yen weakens and AI jitters ease

Tokyo stock market today: Nikkei hits new record as yen weakens and AI jitters ease

Japan’s Nikkei 225 rose 1.1% to a record 58,047.89 in early Wednesday trade, boosted by a weaker yen and steady AI sentiment. The yen fell to 155.74 per dollar after reports of political doubts over further Bank of Japan rate hikes. January’s services producer price index increased 2.6% year-on-year, matching December. Foreign investors bought a net 1.42 trillion yen of Japanese stocks in the week to Feb. 14.
25 February 2026
···
Tokyo Stock Market Today (Nov 28–29, 2025): Nikkei 225 Ends Week Higher but Suffers Worst November Since 2011 as Fed Cut Bets and Micron AI Deal Shape Outlook

Tokyo Stock Market Today (Nov 28–29, 2025): Nikkei 225 Ends Week Higher but Suffers Worst November Since 2011 as Fed Cut Bets and Micron AI Deal Shape Outlook

The Nikkei 225 closed Friday at 50,253.91, up 0.17% for the day and 3.4% for the week, but down over 4% for November—its worst November since 2011. Micron announced a ¥1.5 trillion investment in a new AI memory chip plant in Hiroshima, with up to ¥500 billion in government subsidies. The Topix ended at 3,378.44, up 0.29%. The Bank of Japan signaled possible rate hikes for December.
29 November 2025
···
Furukawa Electric (TYO: 5801) Rallies on New TOFC™ Copper Breakthrough – Stock News & Analysis for November 27, 2025

Furukawa Electric (TYO: 5801) Rallies on New TOFC™ Copper Breakthrough – Stock News & Analysis for November 27, 2025

Furukawa Electric shares closed up 2.88% at ¥9,480 in Tokyo on Thursday after unveiling TOFC™, a new heat-resistant copper for power semiconductors. The stock rebounded about 7% since a sharp drop on November 21, with trading volume near 2.98 million shares. Investors remain focused on the company’s data-center and green-energy projects following strong first-half earnings.
27 November 2025
··

Stock Market Today

  • Parabilis Plans IPO to Fund Phase 3 Trial for Tumor Drug Following Regeneron Deal
    May 20, 2026, 5:56 AM EDT. Parabilis Medicines, a Massachusetts biotech, is preparing for an initial public offering (IPO) to finance the phase 3 trial of its tumor drug zolucatetide, targeting rare desmoid tumors. The drug, which inhibits the Wnt/β-catenin pathway implicated in many cancers, recently received FDA fast-track status. Proceeds will also support phase 1 trials for additional cancers. Parabilis secured a $50 million upfront payment and a $75 million equity investment from Regeneron in a deal to explore Parabilis' helicon peptide platform. The firm boasts over $300 million in cash from prior funding rounds. CEO Mathai Mammen aims to grow Parabilis into a fully integrated research, development, manufacturing, and commercialization company, relying on partnerships to finance its ambitions.

Latest articles

San Antonio’s New Battery Bet Comes Just as CPS Outages Get Longer

San Antonio’s New Battery Bet Comes Just as CPS Outages Get Longer

20 May 2026
OCI Energy and CPS Energy have begun building a 120-megawatt battery storage facility in southeastern Bexar County, aiming for commercial operation in 2027. The project follows a rise in average outage duration for CPS Energy customers to 75.38 minutes in 2025. OCI will own the facility, with CPS holding operational control. ING is financing construction, and LG Energy Solution Vertech is supplying batteries.
Co-Diagnostics Jumps; $3 Million Deal Looms

Co-Diagnostics Jumps; $3 Million Deal Looms

20 May 2026
Co-Diagnostics announced a $3 million private placement after its stock surged 43.8% Tuesday, then fell 13.3% in after-hours trading. The company will sell 1.65 million shares or pre-funded warrants, plus warrants for up to 3.29 million more shares, nearly doubling its share count. The move follows its completion of a Bundibugyo virus assay as Ebola spreads in Congo and Uganda. Co-Diagnostics reported $8.2 million in cash at March 31.
Micron Stock Just Dodged the Nasdaq Selloff. A Samsung Strike Could Be Its Next Jolt

Micron Stock Just Dodged the Nasdaq Selloff. A Samsung Strike Could Be Its Next Jolt

20 May 2026
Micron Technology shares rose 2.5% Tuesday to $698.74, lifting its market value near $798 billion as the Nasdaq fell. Analysts cited tight memory supply and strong DRAM and NAND pricing. A planned strike by 48,000 Samsung workers Thursday could disrupt global memory supply, potentially raising prices. Micron recently sampled 256GB DDR5 server modules to partners.
Go toTop